vicente valenzuela

14 years of basic research in neurodegenerative diseases. 10 years in gene therapy R&D research. 2 postdocs. 10+ years in project managing. One patent filled and licensing process. Awarded with 13 National and International projects, fellowships, or prizes. Co-author of 18
articles indexed in Pubmed. Skills in cellular and molecular biology, histology, mouse handling and testing, microsurgery, electrophysiology, virus work.

PPD / Thermo Fisher Scientific
Associate Project Manager | Aug 2022 – April 2023
Co-leader in different global clinical studies at different stages: Bid Defense, Start
up, Development. Vendor and financial Management. Biotech and Pharma as
Sponsors.

BrainLat Institute – Universidad Adolfo Ibáñez
Project Manager - Clinical Coordinator| June 2022 – July 2022
Machine learning for the diagnosis and multimodal profile of neurodegenerative
diseases based on miRNA circulating miRNA in Latin American population.

Biomedical Neuroscience Institute – UCB Biopharma
Project Lead - Scientific Director | Sep 2019 - May 2022
Preclinical R&D Project: Gene therapy to treat ALS. 5 people in charge,
(accountability, quality manager and 3 research assistants). Roles: project design
(scientific and budget), execution, data analysis and report.

Biomedical Neuroscience Institute – ALS Association
Milton Safenowitz Postdoctoral Fellow | Jun 2016 – Jun 2018
Principal Investigator. Development and evaluation of a gene therapy to treat
experimental ALS. Roles: Design and execution, molecular biology, histology, motor
tests, report. Patenting and licensing of the product.

Corporación ELA Chile
Scientific Advisor | 2017-2023
Scientific Advisory to amyotrophic lateral sclerosis patients, relatives, and
caregivers about scientific evidence of current and potential treatments. Research
collaboration with KOLs. Clinical study counseling. Public and personal meetings.

Co-author of 18 articles indexed in Pubmed. 7 years of Scientific Advisory in ALS. 4
years of teaching in different Universities. 4+ years in Pharma Industry/CRO. MSL and GCP courses.